Aim To assess the clinical utility of FDG-PET as a diagnostic aid for differentiating
Alzheimer's disease (AD; both typical and atypical forms), dementia with Lewy bodies (DLB) …

Molecular imaging has proven to be a powerful tool for investigation of parkinsonian
disorders. One current challenge is to identify biomarkers of early changes that may predict …

The spreading hypothesis of neurodegeneration assumes an expansion of neural
pathologies along existing neural pathways. Multimodal neuroimaging studies have …

Background Rapid advances in neuroimaging technologies in the exploration of the living
human brain also apply to movement disorders. However, the accurate diagnosis of …

Introduction Differential diagnosis of dementia with Lewy bodies (DLB), Parkinson's disease
with dementia (PDD), Parkinson's disease (PD) and Alzheimer's disease (AD) is …

Parkinson's disease (PD) is a common neurodegenerative disorder, characterized by motor
and non-motor symptoms. Dementia is one of the most relevant non-motor symptoms …

The aim of this study was to examine the relationship between the presence of glucose
hypometabolism (GHM) and brain iron accumulation (BIA), two potential pathological …

ABSTRACT Background Whether dementia with Lewy bodies (DLB) and Parkinson's
disease (PD) dementia (PDD) represent the same disease, distinct entities, or conditions …

Tau protein aggregations are a hallmark of amyloid-associated Alzheimer disease and
some forms of non–amyloid-associated frontotemporal lobar degeneration. In recent years …

Abstract Purpose of Review The aims of the study were to review recent advances in
molecular imaging in the Lewy body dementias (LBD) and determine if these may support …